Disparities in Multisystem Inflammatory Syndrome in Children and COVID-19 Across the Organ Dysfunction Continuum

doi:10.1001/jamanetworkopen.2022.49552

Comment

. 2023 Jan 3;6(1):e2249552.

doi: 10.1001/jamanetworkopen.2022.49552.

Disparities in Multisystem Inflammatory Syndrome in Children and COVID-19 Across the Organ Dysfunction Continuum

Blake Martin¹, Suchitra Rao², Tellen D Bennett^{1

3}

Affiliations

¹ Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora.
² Sections of Infectious Diseases and Hospital Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora.
³ Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora.

PMID: 36602806
PMCID: PMC10349277
DOI: 10.1001/jamanetworkopen.2022.49552

Comment

Disparities in Multisystem Inflammatory Syndrome in Children and COVID-19 Across the Organ Dysfunction Continuum

Blake Martin et al. JAMA Netw Open. 2023.

. 2023 Jan 3;6(1):e2249552.

doi: 10.1001/jamanetworkopen.2022.49552.

Authors

Blake Martin¹, Suchitra Rao², Tellen D Bennett^{1

3}

Affiliations

¹ Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora.
² Sections of Infectious Diseases and Hospital Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora.
³ Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora.

PMID: 36602806
PMCID: PMC10349277
DOI: 10.1001/jamanetworkopen.2022.49552

No abstract available

PubMed Disclaimer

Comment on

Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19.
Encinosa W, Moon K, Figueroa J, Elias Y. Encinosa W, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2244975. doi: 10.1001/jamanetworkopen.2022.44975. JAMA Netw Open. 2023. PMID: 36602804 Free PMC article.

Cited by

Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.
Truong DT, Trachtenberg FL, Hu C, Pearson GD, Friedman K, Sabati AA, Dionne A, Oster ME, Anderson BR, Block J, Bradford TT, Campbell MJ, D'Addese L, Dummer KB, Elias MD, Forsha D, Garuba OD, Hasbani K, Hayes K, Hebson C, Jone PN, Krishnan A, Lang S, McCrindle BW, McHugh KE, Mitchell EC, Morrison T, Muniz JC, Payne RM, Portman MA, Russell MW, Sanil Y, Shakti D, Sharma K, Shea JR, Sykes M, Shekerdemian LS, Szmuszkovicz J, Thacker D, Newburger JW; MUSIC Study Investigators. Truong DT, et al. JAMA Pediatr. 2025 Mar 1;179(3):293-301. doi: 10.1001/jamapediatrics.2024.5466. JAMA Pediatr. 2025. PMID: 39804656
Relationship between thyroid function and lipid atherogenic profile in pediatric patients with multisystem inflammatory syndrome associated with COVID-19.
Calcaterra V, De Santis R, Braghieri D, Zanelli S, Zuccotti G. Calcaterra V, et al. Front Pediatr. 2024 Oct 29;12:1456545. doi: 10.3389/fped.2024.1456545. eCollection 2024. Front Pediatr. 2024. PMID: 39534251 Free PMC article.

References

1. Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325(11):1074–1087. - PMC - PubMed
1. Martin B, DeWitt PE, Russell S, et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. Jama Netw Open. 2022;5(2):e2143151–e2143151. - PMC - PubMed
1. Farooqi KM, Chan A, Weller RJ, et al. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics. 2021;148(2). - PubMed
1. Encinosa W MK, Figueroa J, and Elias Y. Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19: An Observational Study of 4,000 U.S. Hospitals. Jama Netw Open. 2022. - PMC - PubMed
1. Bembea MM, Agus M, Akcan-Arikan A, et al. Pediatric organ dysfunction information update mandate (PODIUM) contemporary organ dysfunction criteria: executive summary. Pediatrics. 2022;149(Supplement_1):S1–S12. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

Grants and funding

R01 HD105939/HD/NICHD NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325(11):1074–1087. - PMC - PubMed

[2] Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325(11):1074–1087. - PMC - PubMed

[3] Martin B, DeWitt PE, Russell S, et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. Jama Netw Open. 2022;5(2):e2143151–e2143151. - PMC - PubMed

[4] Martin B, DeWitt PE, Russell S, et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. Jama Netw Open. 2022;5(2):e2143151–e2143151. - PMC - PubMed

[5] Farooqi KM, Chan A, Weller RJ, et al. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics. 2021;148(2). - PubMed

[6] Farooqi KM, Chan A, Weller RJ, et al. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics. 2021;148(2). - PubMed

[7] Encinosa W MK, Figueroa J, and Elias Y. Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19: An Observational Study of 4,000 U.S. Hospitals. Jama Netw Open. 2022. - PMC - PubMed

[8] Encinosa W MK, Figueroa J, and Elias Y. Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19: An Observational Study of 4,000 U.S. Hospitals. Jama Netw Open. 2022. - PMC - PubMed

[9] Bembea MM, Agus M, Akcan-Arikan A, et al. Pediatric organ dysfunction information update mandate (PODIUM) contemporary organ dysfunction criteria: executive summary. Pediatrics. 2022;149(Supplement_1):S1–S12. - PMC - PubMed

[10] Bembea MM, Agus M, Akcan-Arikan A, et al. Pediatric organ dysfunction information update mandate (PODIUM) contemporary organ dysfunction criteria: executive summary. Pediatrics. 2022;149(Supplement_1):S1–S12. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Disparities in Multisystem Inflammatory Syndrome in Children and COVID-19 Across the Organ Dysfunction Continuum

Affiliations

Disparities in Multisystem Inflammatory Syndrome in Children and COVID-19 Across the Organ Dysfunction Continuum

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Supplementary concepts

Grants and funding

LinkOut - more resources

Full Text Sources

Medical